Dengue is a disease transmitted by a virus of the flavivirus family, the so-called dengue virus (DENV). There are four serotypes: DENV-1, DENV-2, DENV-3, or DENV-4, so a person can be infected up to four times in their lifetime. Dengue transmission occurs through the bite of an Aedes species mosquito, but it can also be passed from mother to child. On rare occasions, it can be transmitted through a blood transfusion, organ transplant, or prick with an infected needle. Symptoms can range from mild to severe, requiring hospitalization or even death within hours. The most common symptoms are fever, nausea, vomiting, rash, aches and pains. In the most severe cases, that of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), it can cause shock and internal bleeding. Regarding its treatment, there is no specific medication and, as a prevention, it is recommended to avoid endemic areas, protect yourself from mosquito bites and vaccination. The diagnosis of dengue is made by detecting elements of the virus or immune components of human origin produced in response to the virus. Early detection of the disease reduces mortality rates from severe dengue to below 1%.
Dengue is found in tropical and subtropical climates around the world. The global incidence of dengue has grown dramatically in recent decades. Almost half of the world's population lives in areas at risk of dengue fever. Every year, around 400 million infections occur, 100 million get sick, and 40 thousand die from severe dengue.
At Rekom Biotech, we desing and manufacture IVD reagents for diagnosis of Dengue. Do not hesitate to contact us!
Protein design from scratch, always trying to improve its antigenic capacity.
Search for the best DNA construction according to the design phase.
Selection of the best expression system for the protein.
Process adjustments to achieve an optimal seed, and the process to isolate our protein from the obtained seed.
Validation and full quality control.